Success in trials for Huntington’s and Spinal Muscular Atrophy raises hopes that diseases such as Alzheimer’s and ALS could be tackled using a new class of drugs
They are diseases that threaten more than physical health: memories, personality, and the ability to move and speak are incrementally stolen. And until this year neurodegenerative diseases, from Alzheimer’s to ALS, had been entirely unstoppable.
However, a breakthrough in Huntington’s disease this week suggests this bleak picture could be about to change. The landmark trial was the first to show that the genetic defect that causes Huntington’s could be corrected, raising hopes that the drug will become the first to slow the progress of the disease – or even stop it.
Continue reading...posted from The Guardian
Thank you for reading the This may be a turning point in treating neurodegenerative diseases on Syria News Kit If you want to spread this News please include links as Source, and if this News useful please bookmark this page in your web browser, by pressing Ctrl + D on your keyboard button, Or click the share button to place it on your profile.
Note: Only a member of this blog may post a comment.